Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment
- 1 November 2013
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 17 (3) , 894-906
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health/National Institute of Allergy and Infectious Diseases (R15 AR062883)
This publication has 103 references indexed in Scilit:
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisArthritis Care & Research, 2012
- Silencing of microRNA‐21 in vivo ameliorates autoimmune splenomegaly in lupus miceEMBO Molecular Medicine, 2011
- miR-21 and miR-214 Are Consistently Modulated during Renal Injury in Rodent ModelsThe American Journal of Pathology, 2011
- MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseasesTranslational Research, 2011
- Current and novel therapeutics in the treatment of systemic lupus erythematosusJournal of Allergy and Clinical Immunology, 2011
- STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to CancerMolecular Cell, 2010
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell TransformationCell, 2009
- TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTENNature Cell Biology, 2009
- Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohortArthritis Care & Research, 2009
- Anti–α8 integrin immunoliposomes in glomeruli of lupus‐susceptible mice: A novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosusArthritis & Rheumatism, 2008